FMP
Mar 15, 2023 9:39 AM - Davit Kirakosyan
89bio, Inc. (NASDAQ:ETNB) shares rose more than 10% since the company’s reported Q4 results on Friday. R&D came in at $19.1 million and SG&A was $6.3 million. Cash and equivalents ended the quarter at $188.2 million. The company reiterated the March timeline for key ph.IIb pegoza NASH data.
Analysts at RBC Capital said they expect similar data to AKRO's FGF21 analog and believe this will lead to a meaningful stock upside. According to the analysts, pivotal studies in SHTG, an underappreciated opportunity with a low-risk path, remain on track and provide a high valuation floor. The analysts continue to see an attractive buying opportunity into the upcoming data.
Sep 11, 2023 - Rajnish Katharotiya
During this post we are going to perform an industry analysis with Python. We will build, analyse and compare all stocks operating within an industry. To do so, we will pick an industry and get all important financial metrics for companies operating in that industry. Then, we will use a couple of fi...
Sep 11, 2023 - Rajnish Katharotiya
Price to Earnings is one of the key metrics use to value companies using multiples. The P/E ratio and other multiples are relative valuation metrics and they cannot be looked at in isolation. One of the problems with the P/E metric is the fact that if we are in the peak of a business cycle, earni...
Sep 11, 2023 - Rajnish Katharotiya
Would you like to know how your portfolio is performing and how much risk you are taking? In this post, you will learn how to measure portfolio risk and calculate portfolio returns using Python. We will see step by step how to calculate the risk and returns of a portfolio containing four stocks Appl...